Freestone Capital Holdings’s Gritstone bio, Inc. Common Stock GRTS Stock Holding History

Freestone Capital Holdings’s Portfolio GRTS Stock Details GRTS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-789,719	Closed	-$458K	–	480
2024 Q3	$458K	Buy	789,719 +557,061	+239%	+$312K	0.02%	303
2024 Q2	$144K	Buy	+232,658	New	+$197K	0.01%	441

Other funds holding GRTS

BBA

Baader Bank Aktiengesellschaft Unterschleissheim, Germany $1.33B AUM 47.35% 1-Year Est. Return

EWA

EverSource Wealth Advisors Birmingham, Alabama $2.97B AUM 28.74% 1-Year Est. Return

Freestone Capital Holdings's GRTS Position: Q4 2024 in Review

Freestone Capital Holdings sold out of Gritstone bio, Inc. Common Stock (GRTS) in Q4 2024, closing a stake of 789,719 shares — an estimated $458K sold.

Freestone Capital Holdings first reported a position in GRTS in Q2 2024 and held it in 2 quarters. The position peaked at $458K in Q3 2024. 6 funds tracked by Wall St. Rank hold GRTS as of Q4 2024.

Freestone Capital Holdings reported no remaining Gritstone bio, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
Freestone Capital Holdings sold 789,719 Gritstone bio, Inc. Common Stock shares in Q4 2024, an estimated $458K.
Freestone Capital Holdings first reported a position in Gritstone bio, Inc. Common Stock in Q2 2024 and held it in 2 quarters.
Freestone Capital Holdings's Gritstone bio, Inc. Common Stock position peaked at $458K in Q3 2024.
6 funds tracked by Wall St. Rank held Gritstone bio, Inc. Common Stock as of Q4 2024.

Based on Freestone Capital Holdings's 13F filing for Q4 2024, filed 6 Feb 2025.